Program Overview
Recognizing that there is a rapid expansion of Biosimilars usage in clinical practice, and that the role of an oncology pharmacist is evolving and further integrating as a key member of a multidisciplinary healthcare team, ISOPP developed the Oncology Pharmacotherapy and Applications of Biosimilars (OPAB) online education program that supports oncology pharmacists to safely and confidently introduce Biosimilars into their clinical practice and multidisciplinary healthcare team.
ISOPP presents this education program in a novel way by giving both fundamentals and advanced aspects of 1) pharmacotherapy of various cancers, 2) implementation of biosimilars in oncology practice and 3) interpretation of available scientific and regulatory data and pharmacist’s recommendations for using biosimilars in different cancers. The program consists of 10 online modules (25 hours of education).
Target Audience
ISOPP's OPAB program is for ISOPP Members who are oncology pharmacists and have practiced for at least one year in the area of oncology pharmacy.
Learning Objectives
Registration
Continuing Education Credits
Accreditation

Program Date
Faculty

Disclaimer and Disclosures
Financial Support

Required Technology
The program is offered using Opigno, a browser based learning management system. A computer with an internet connection is required.
Do you have any questions and/or technical issues? Please contact the Society Management Office via email at register@isopp.org for assistance.